Drugs / NNC0363-0845
Trials 2 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT05134987 | Dec 2021 → May 2022 | type 1 diabetes mellitus | Novo Nordisk A/S | Completed | No outcome recorded |
| Phase 1 | NCT04569994 | Sep 2020 → Jun 2021 | type 1 diabetes mellitus | Novo Nordisk A/S | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | NNC0363-0845 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT04569994 ↗ |
| Route | Subcutaneous | “A single dose administered s.c. (subcutaneously, under the skin)” NCT04569994 ↗ |